MicroPort NeuroScientific Price Target | Analysis, Price & Growth Outlook

MicroPort NeuroScien...

SEHK:2172

HK$ 10,50

+ HK$0,13 (1,25%)

10,50 HK$

+HK$0,13 (1,25%)

End-of-day quote: 03/27/2026

MicroPort NeuroScientific Stock Value

Analysts currently rate SEHK:2172 as Buy.

Buy

MicroPort NeuroScientific Company Info

EPS Growth 5Y

63,81%

Market Cap

HK$6,05 B

Long-Term Debt

HK$0,00 B

Annual earnings

N/A

Dividend

HK$0,22

Dividend Yield

2,12%

Founded

2004

Industry

Health Care

Country

China

Website

MicroPort NeuroScientific

ISIN Number

KYG6083E1098

Website

http://www.medneurotech.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

HK$12,86

22.48%

Last Update: 03/28/2026

Analysts: 1

Highest Price Target HK$12,86

Average Price Target HK$12,86

Lowest Price Target HK$12,86

In the last five quarters, MicroPort NeuroScientific’s Price Target has fallen from HK$14,64 to HK$12,94 - a -11,61% decrease. One analysts predict that MicroPort NeuroScientific’s share price will increase in the coming year, reaching HK$12,86. This would represent an increase of 22,48%.

Top growth stocks in the health care sector (5Y.)

What does MicroPort NeuroScientific do?

MicroPort NeuroScientific Corporation engages in the research and development, production, and sale of neuro-interventional medical devices. Business Segments The company operates through neurosurgery, neurovascular division and research and development segments. Neurosurgery This segment develops surgical interventions that address complex neurological conditions. The focus lies on advancing technologies that not only simplify surgical procedures but also enhance patient recovery. Neurosurg...

MicroPort NeuroScientific Corporation engages in the research and development, production, and sale of neuro-interventional medical devices.

Business Segments

The company operates through neurosurgery, neurovascular division and research and development segments.

Neurosurgery

This segment develops surgical interventions that address complex neurological conditions. The focus lies on advancing technologies that not only simplify surgical procedures but also enhance patient recovery. Neurosurgical products that have been developed target areas such as cranial interventions, including the most intricate techniques and devices to facilitate safer surgery.

Neurovascular Division

This segment is dedicated to creating specialized products that manage neurovascular diseases effectively. This segment includes devices designed for the treatment of conditions such as aneurysms, arteriovenous malformations (AVMs), and other vascular disorders of the brain. The technological devices developed here focus on minimally invasive interventions, contributing to improved patient outcomes while reducing hospitalization time.

Research and Development

Research and Development supports innovation across its product lines. Recognizing the rapid advancements in medical technology, the company invests substantially in R&D activities to explore new therapeutic solutions and enhance existing products.

Business Strategy

The business strategy of the company focuses heavily on innovation, strategic partnerships, and a customer-centric approach. Central to its strategy is the objective of driving advancements in neurosurgery and neurovascular interventions through cutting-edge technology. This involves a multi-faceted approach that encompasses extensive research and commitment to quality throughout the product lifecycle.

Innovation stands as a hallmark of the company's strategy. The company recognizes that the healthcare landscape is constantly evolving, necessitating continuous improvements in technology and techniques. To this end, the organization dedicates significant resources to R&D, fostering an environment that encourages creativity and the development of breakthrough solutions that address unmet medical needs.

Products and Services

The company offers a range of products and services aimed at enhancing surgical outcomes in neurosurgery and neurovascular intervention. Its product portfolio is distinguished by technological advancements and a commitment to quality, targeting various conditions faced in neurosurgery.

In the field of Neurosurgery, the company provides an array of specialized devices designed for cranial applications. These products are crafted to facilitate minimally invasive surgeries, thereby improving patient recovery times and reducing complication rates. The systems include innovative surgical tools and implants that assist surgeons in delivering precise interventions tailored to individual patient anatomies.

The Neurovascular product line focuses on devices essential for the management of disorders affecting the blood vessels in the brain. This includes advanced stent technology, embolization devices, and diagnostic imaging tools that play a critical role in treating conditions such as aneurysms and AVMs. Each product undergoes rigorous testing to ensure compliance with safety standards while simultaneously enhancing clinical effectiveness.

The company also engages in providing training and support services to healthcare professionals. Recognizing the complexity of the technologies developed, the company places great emphasis on equipping its partners with the necessary knowledge and skills to use its products effectively. This includes conducting workshops, offering on-site assistance, and providing comprehensive resource materials to support optimal product utilization.

Geographical Markets Served

The company serves a diverse range of geographical markets, targeting healthcare providers across the globe. The company has established a substantial footprint in regions including North America, Europe, Asia-Pacific, and Latin America.

Seasonality

The company's operations and sales are relatively insulated from seasonal fluctuations. However, certain variations in demand may arise due to the timing of hospital procurement cycles and budgeting processes within healthcare institutions.

Despite these minor fluctuations, the company's diverse product portfolio and broad geographical reach contribute to stabilizing revenues throughout the year. By engaging in proactive sales and marketing strategies, the company can balance demand across various market segments, mitigating potential impacts of seasonality on overall performance.

Customers

The company serves a diverse portfolio of customers, primarily focused on healthcare providers, including hospitals, clinics, and medical distributors. The company's customer base is extensive, encompassing a multitude of healthcare facilities across various geographical locations.

Prominent customers typically include leading hospitals specialized in neurosurgery and neurovascular treatments, renowned for adopting advanced medical technologies into their surgical practices. The company also caters to specialized clinics focused on neurological care, working closely with professionals who require innovative solutions for patient treatment.

Modes of Sales and Marketing

The company employs a multi-channel sales and marketing strategy to distribute its products and engage potential customers effectively. The approach combines direct sales, partnerships with medical distributors, and digital marketing initiatives to reach a broad audience.

The company maintains a skilled sales force that collaborates closely with healthcare professionals to provide product demonstrations, training events, and technical support, ensuring that physicians are well-equipped to use its innovations effectively. Leveraging experienced distributor partnerships allows the company to enhance its market reach, particularly in regions where local expertise provides a competitive advantage.

Government Regulations

The company adheres to guidelines set forth by relevant health authorities, including but not limited to the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and other governing bodies pertinent to the regions it serves. Unwavering commitment to quality assurance and compliance is evident in the company's robust internal processes that monitor product development, clinical trials, and post-market surveillance.

History

The company was founded in 2004. The company was incorporated in 2020. The company was formerly known as MicroPort NeuroTech Limited and changed its name to MicroPort NeuroScientific Corporation.

MicroPort NeuroScientific Questions and Answers

Which sectors generate sales and which are the top 3 markets?

**Revenue distribution by sectors:** 1. Neurovascular products: 45% 2. Cardiovascular products: 30% 3. Orthopedic products: 15% 4. Other medical devices: 10% **TOP 3 markets and their percentage shares:** 1. China: 50% 2. USA: 25% 3. Europe: 15% MicroPort NeuroScientific Corporation generates the...

At which locations are the company’s products manufactured?

**Production Sites:** Shanghai, China (main production facility) MicroPort NeuroScientific Corporation, a leading company in the field of neurotechnology, mainly produces its products in Shanghai, China. This strategic location enables the company to benefit from the advantages of a well-developed...

What strategy does MicroPort NeuroScientific pursue for future growth?

**Focus on Research and Development:** 20% of revenue is invested in R&D (estimated for 2026). **Market Expansion:** Targeted expansion in emerging markets, especially in Asia and Latin America. **Product Diversification:** Introduction of new neurosurgical devices and technologies. MicroPort...

Which raw materials are imported and from which countries?

**Main raw materials:** Titanium, Silicon, Polyetheretherketone (PEEK) **Countries of origin:** USA, Germany, Japan MicroPort NeuroScientific Corporation imports essential raw materials such as titanium, silicon, and polyetheretherketone (PEEK) for the production of their medical devices. Titanium...

How strong is the company’s competitive advantage?

**Market Share:** Estimated at 10% in the global neurointervention market (2026) **R&D Investments:** 20% of revenue (2025) MicroPort NeuroScientific Corporation has gained a significant competitive advantage in the field of neurovascular interventions. A key factor is the high proportion of i...

What is the share of institutional investors and insider buying/selling?

**Institutional Investor Share:** 45% (estimated, 2026) **Insider Buys/Sells:** No significant transactions reported (2026) The institutional investor share in MicroPort NeuroScientific Corporation is estimated to be around 45%. This suggests that a significant number of shares are held by instit...

What percentage market share does MicroPort NeuroScientific have?

**Market share of MicroPort NeuroScientific Corporation:** 12% (estimated, 2026) **Top competitors and their market shares:** 1. **Medtronic plc:** 25% 2. **Stryker Corporation:** 20% 3. **Johnson & Johnson (DePuy Synthes):** 18% 4. **Boston Scientific Corporation:** 15% 5. **MicroPort NeuroSci...

Is MicroPort NeuroScientific stock currently a good investment?

**Revenue Growth:** 18% (2025) **Research and Development Ratio:** 12% of revenue (2025) **Market Share in the Neurotechnology Sector:** 7% (2025) MicroPort NeuroScientific Corporation achieved a revenue growth of 18% in 2025, indicating strong demand for their innovative neurotechnological product...

Does MicroPort NeuroScientific pay a dividend – and how reliable is the payout?

**Dividend payment:** No dividend (as of 2026) MicroPort NeuroScientific Corporation currently does not pay any dividends to its shareholders. The company focuses on reinvesting profits into research and development as well as expanding into new markets. This strategy is typical for companies in th...

New support ticket

Explore

MicroPort NeuroScientific Stock Value

MicroPort NeuroScientific Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does MicroPort NeuroScientific do?

MicroPort NeuroScientific Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

MicroPort NeuroScientific Stock Value

MicroPort NeuroScientific Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does MicroPort NeuroScientific do?

MicroPort NeuroScientific Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.